InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Friday, 04/25/2014 7:54:41 PM

Friday, April 25, 2014 7:54:41 PM

Post# of 130506
Thanks Warp for the audio files: Key takeaways from the conference call that I liked: (obviously there are many but what I liked I will list)

1. There is soon to be a contract for Amarantus to move in to a manufacturing facility coming up I'm surprised not many mentioned this unless I missed it somewhere

2. Amarantus CEO has his father presenting at a conference next week about Phenoguard which can be a new protein family (meaning an increased portfolio position like MANF) which would increase value of the company.

3. Another thing I liked was that BD will finish lympro and hand it off to another company to commercialize. Depending what company it is this could be a very huge catalyst for the stock.

4. If MANF is successful in Wolfram's Syndrome it could be branched to type I and type II diabetes.

There are too many good things to list so I just chose some to list!